Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Keystone Bio logo — company profile

Keystone Bio

Founded 2018 United States Saint Louis, United States 5 employees Venture round Total: $5.00M Biotechnology, Health Care +1

General Information

Company Name Keystone Bio
Founded Year 2018
Location United States Saint Louis, United States
Founders / Decision Makers
Team member Team member
Employees 5
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Keystone Bio. To contact Keystone Bio, visit keystonebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Keystone Bio compare?

A PDF of Keystone Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Keystone Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Keystone Bio

Keystone Bio (KB) is a clinical stage, biopharmaceutical company founded in 2018 and headquartered in the United States. The company specializes in pioneering novel disease-modifying, precision, anti-bacterial therapeutics, preventives, and companion diagnostics. KB's flagship product, PrevEvent, is a precision bio-therapeutic that targets Porphyromonas gingivalis (Pg), a bacterial driver of systemic chronic inflammation associated with various inflammatory disease states, including heart disease and dementia/Alzheimer's disease. The anti-inflammatory therapeutic market is projected to reach $130.6 billion (US) by 2026, reflective of the substantial potential for KB's innovative solutions. Keystone Bio's groundbreaking discoveries have broken the single agent, single disease paradigm by identifying Pg as the primary microbial pathogen driving inflammation and its association with multiple NLRP3/IL-1β pathway mediated diseases. These diseases encompass a wide range, such as cardiovascular and coronary artery disease, large vessel disease/stroke, neuro-cognitive vascular dementia, Alzheimer's disease, T2Diabetes, aspiration pneumonia, abdominal aneurysm, rheumatoid arthritis, as well as orphan diseases like fatty liver disease, non-alcoholic steatohepatitis (NASH), non-smokers lung cancer, and esophageal cancer. With a significant $5.00M Venture Round investment in 29 April 2019, KB's innovative approach to addressing unmet medical needs has attracted attention for its potential to transform healthcare outcomes and tap into a sizable market poised for growth.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $5.00M -
29 Apr 2019

FAQ About Keystone Bio

Keystone Bio (KB) is a clinical stage, biopharmaceutical company pioneering novel disease-modifying, precision, anti-bacterial therapeutic, preventive and companion diagnostic. KB is targeting an important, and largely unaddressed, bacterial driver of systemic chronic inflammation that significant...
Keystone Bio was founded in 2018.
Keystone Bio is headquartered in Saint Louis, United States.
Keystone Bio operates in Biotechnology, Health Care and Pharmaceutical.
Keystone Bio has approximately 5 employees.
Keystone Bio has completed 1 funding round, raising a total of $5.00M. The latest funding stage is Venture round.

We're actively collecting intelligence on Keystone Bio.

Source: BounceWatch company record for Keystone Bio, https://bouncewatch.com/company/keystone-bio, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes